Paiella S, et al. - In a subset of patients with locally advanced pancreatic ductal adenocarcinoma (PDAC) submitted to radiofrequency ablation (RFA), researchers determined whether the assessment of SMAD4 status was a useful way to select the patients. As per findings, SMAD4 analysis could identify a subgroup of subjects with improved survival within these patients, who likely benefited from tumor ablation